| scholarly article | Q13442814 |
| P2093 | author name string | R. S. Epstein | |
| S. D. Silberstein | |||
| S. L. Hartmaier | |||
| N. C. Santanello | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | headache | Q86 |
| questionnaire | Q747810 | ||
| migraine | Q133823 | ||
| quality of life | Q13100823 | ||
| P304 | page(s) | 330-337 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | Validation of a New Quality of Life Questionnaire for Acute Migraine Headache | |
| P478 | volume | 35 |
| Q35660944 | A review of health-related workplace productivity loss instruments |
| Q35920017 | Acupuncture as analgesia for low back pain, ankle sprain and migraine in emergency departments: study protocol for a randomized controlled trial |
| Q34759967 | Assessing health-related quality of life in patients with migraine |
| Q33575522 | Burden of migraine. A review of its socioeconomic impact |
| Q39425621 | Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group |
| Q39402029 | Determinants of migraine-specific quality of life |
| Q39437820 | Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group |
| Q34889352 | Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial |
| Q34528287 | Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine |
| Q64964853 | Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. |
| Q39451199 | Improvement in migraine-specific quality of life in a clinical trial of rizatriptan |
| Q34387249 | Influence of treatments for migraine on quality of life: literature integrative review |
| Q44904196 | Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine |
| Q46142932 | Large-scale screening and subsequent effects of migraine treatment on the work floor in the Netherlands. |
| Q53446565 | Long-term follow-up of patients treated for chronic headache with analgesic overuse. |
| Q39386394 | Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings |
| Q36260215 | Meeting patient expectations in migraine treatment: what are the key endpoints? |
| Q46079568 | Migraine and telcagepant [corrected]. |
| Q28221721 | Patient satisfaction with eletriptan in the acute treatment of migraine in primary care |
| Q28378036 | Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine |
| Q35771980 | Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results |
| Q53314889 | Quality of life in young Italian patients with primary headache. |
| Q50265031 | Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine |
| Q45018129 | Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine |
| Q37368387 | Randomized, controlled trial of telcagepant for the acute treatment of migraine |
| Q39388552 | Rizatriptan RPD for severe migraine in the emergency department—a multicenter study |
| Q83764348 | Rizatriptan in the treatment of migraine |
| Q39354736 | Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial |
| Q36248065 | The three dimensions of headache impact: pain, disability and affective distress |
| Q48436592 | The validation of a new comprehensive headache-specific quality of life questionnaire |
| Q35658657 | Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders |
| Q40091928 | Toward an epidemiology of refractory migraine: current knowledge and issues for future research |
| Q39437824 | Validation of a migraine work and productivity loss questionnaire for use in migraine studies |
| Q53524572 | Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). |
| Q39803883 | Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life |
Search more.